Chemotherapy Hospitals Specialty Pharmacies 
Pharmacy Times
JULY 16, 2025
The findings of the DeLLphi-304 study demonstrated improved OS of tarlatamab compared with single-agent chemotherapy (median OS [mOS], 13.6 The updated definition for HRMM is increasingly important as there is an increased focus on how to improve outcomes for patients with HRMM, functional HRMM, and true extramedullary disease.
Pharmacy Times
JUNE 9, 2025
SHOW MORE Nivolumab (Opdivo) and chemotherapy demonstrated an overall survival benefit at 5 years, affirming its role as a standard of care option. 1,2 Nivolumab and chemotherapy is a standard of care option for resectable non-small cell lung cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 27, 2025
Because of its aggressive nature, MCL is typically treated with combination chemotherapy at diagnosis. For this application, the FDA collaborated with the Australian Therapeutic Goods Administration, Health Canada, and Switzerland’s Swissmedic.
Pharmacy Times
JUNE 9, 2025
Secondary outcomes included rates of specialist referrals and asthma-related emergency department (ED) visits or hospitalizations. Asthma exacerbations requiring acute care were rare but notable: 1 patient visited the ED, and 3 were hospitalized, all of whom were in the track 2 group. N Engl J Med. 2019;380:2020-2030. Subscribe Now!
Pharmacy Times
JUNE 18, 2025
Pharmacy’s Appointment Based Model: medication synchronization align my refills. Impact of a combined pharmacist and social worker program to reduce hospital readmissions. APhA Foundation. Accessed May 5, 2025. Gil M, Mikaitis DK, Shier G, Johnson TJ, Sims S. J Manag Care Pharm. 2013;19(7):558-563. doi:10.18553/jmcp.2013.19.7.558
Pharmacy Times
JUNE 11, 2025
Image Credit: © Chinnapong - stock.adobe.com At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025, an encore presentation from the Pacific Coast Reproductive Society Annual Meeting will highlight findings from a retrospective analysis conducted by Walgreens Specialty Pharmacy.
Pharmacy Times
JUNE 23, 2025
The hospitals and the payment plans would not use your generic drug if you weren’t therapeutically equivalent—we would exclude you,” Soefje said. Historically, CMS would stack all multisource generic 505(b)(2) drugs under the same J-code, Soefje explained. That has changed based upon the [recent] CMS ruling.”
Expert insights. Personalized for you.
65 
Let's personalize your content